Skip to main content

Table 2 Objective tumor response rates in advanced untreated elderly gastric cancer patients

From: Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial

Objective responses

Number (%)

Overall response rate

Overall tumor control rate

Complete Response

2 (4.7%)

19 (45.2%)

32 (76.2%)

Partial Response

17 (40.5%)

  

Stable Disease

13 (31.0%)

  

Disease Progression

10 (23.8%)